Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Maintains Buy on Bio-Techne, Maintains $120 Price Target

Benchmark Maintains Buy on Bio-Techne, Maintains $120 Price Target

Benchmark analyst Robert Wasserman maintains Bio-Techne (NASDAQ:TECH) with a Buy and maintains $120 price target.

byBenzinga Newsdesk

February 3, 2023

1 minute read

Benchmark analyst Robert Wasserman maintains Bio-Techne (NASDAQ:TECH) with a Buy and maintains $120 price target.

Barclays Maintains Equal-Weight on Twilio, Lowers Price Target to $60

By Benzinga Newsdesk

November 7, 7:25 AM

Barclays analyst Ryan Macwilliams maintains Twilio (NYSE:TWLO) with a Equal-Weight and lowers the price target from $90 to $60.

TWLO

Analyst Ratings

Expert Ratings for Dine Brands Global

By Benzinga Insights

October 17, 8:00 AM

Analysts have provided the following ratings for Dine Brands Global (NYSE:DIN) within the last quarter: Bullish Somewhat Bullish…

DIN

First Republic Bank Stock In Freefall With $100B In Deposits Withdrawn, Asset Sales Looming

By Piero Cingari

April 25, 4:45 PM

First Republic Bank (NYSE: FRC) shares saw carnage in Tuesday's session, plummeting 49.37% after the company reported quarterly results.

FRC

Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study

By Vandana Singh

April 18, 1:44 PM

Discover toplines results of Cerevel Therapeutics' Phase 3 TEMPO-3 trial for tavapadon in Parkinson's disease treatment. Statistically significant efficacy and safety findings were revealed.

ABBV

Benchmark Maintains Buy on Bio-Techne, Maintains $120 Price Target

Related Posts

Barclays Maintains Equal-Weight on Twilio, Lowers Price Target to $60

Expert Ratings for Dine Brands Global

First Republic Bank Stock In Freefall With $100B In Deposits Withdrawn, Asset Sales Looming

Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study